Who Paid My Doc
P3 CIT For Solid Tumors Study 2
Research payments
$629,958
Through program year 2024, $629,958 in research payments was reported against P3 CIT For Solid Tumors Study 2, across 60 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $377,340 | 22 |
| 2023 | Research | $175,653 | 15 |
| 2022 | Research | $76,719 | 22 |
| 2021 | Research | $246 | 1 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Karl Schultheiss Boise, ID Named on 4 payments
- Christopher Snead Coushatta, LA Named on 4 payments
- Santosh Nair Orange City, FL Named on 3 payments
- Ralph Boccia Bethesda, MD Named on 3 payments
- Hanny Al-Samkari Boston, MA Named on 3 payments
- Gerald Soff Miami, FL Named on 2 payments
- Nicholas Taylor Fountain Hill, PA Named on 2 payments
- Arvind Chaudhry Spokane, WA Named on 2 payments
- Carl Gray Ogden, UT Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.